All Stories

  1. Puberty‐Promoting Treatment and Psychosocial Well‐Being in Boys With Constitutional Delay of Puberty: A Randomized Controlled Trial
  2. Impact of Aromatase Inhibition on Bone Mineral Density and Structure: A Randomized Controlled Trial in Boys With Delayed Puberty
  3. RFX6 haploinsufficiency predisposes to diabetes through impaired beta cell function
  4. Prenatal, newborn and childhood factors and the timing of puberty in boys and girls
  5. During an 18‐month course of automated insulin delivery treatment, children aged 2 to 6 years achieve and maintain a higher time in tight range
  6. Health-related quality of life and self-reported health status in adolescents with chronic health conditions before transfer of care to adult health care: an international cohort study
  7. Central precocious puberty in boys: secular trend and clinical features
  8. Mechanisms of thyrotropin receptor–mediated phenotype variability deciphered by gene mutations and M453T-knockin model
  9. Congenital hypogonadotropic hypogonadism in a patient with a de novoPOGZmutation
  10. Residual insulin secretion in individuals with type 1 diabetes in Finland: longitudinal and cross-sectional analyses
  11. Pancreatic imaging in MEN1—comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting
  12. Disease control and psychiatric comorbidity among adolescents with chronic medical conditions: a single-centre retrospective study
  13. MiniMed 780G™ in 2- to 6-Year-Old Children: Safety and Clinical Outcomes After the First 12 Weeks
  14. Health-related quality of life in boys with constitutional delay of growth and puberty
  15. Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register
  16. Presentation and diagnosis of childhood-onset combined pituitary hormone deficiency: A single center experience from over 30 years
  17. Timing of puberty and school performance: A population-based study
  18. Circulating Liver-enriched Antimicrobial Peptide-2 Decreases During Male Puberty
  19. The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes
  20. A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY
  21. Gut microbiota develop towards an adult profile in a sex-specific manner during puberty
  22. The aetiology of extreme tall stature in a screened Finnish paediatric population
  23. Cytosolic phosphoenolpyruvate carboxykinase deficiency: Expanding the clinical phenotype and novel laboratory findings
  24. Serum testosterone and oestradiol predict the growth response during puberty promoting treatment
  25. Onset and progression of puberty in Klinefelter syndrome
  26. Bridge study protocol: an international, observational cohort study on the transition of healthcare for adolescents with chronic conditions
  27. First year on commercial hybrid closed‐loop system—experience on 111 children and adolescents with type 1 diabetes
  28. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic
  29. Circulating miR-30b levels increase during male puberty
  30. Impact of SARS-CoV-2 Pandemic and Strategies for Resumption of Activities During the Second Wave of the Pandemic: A Report From Eight Paediatric Hospitals From the ECHO Network
  31. Bone structure assessed with pQCT in prepubertal males with delayed puberty or congenital hypogonadotropic hypogonadism
  32. Motivational Interviewing and Glycemic Control in Adolescents With Poorly Controlled Type 1 Diabetes: A Randomized Controlled Pilot Trial
  33. Familial central precocious puberty: two novel MKRN3 mutations
  34. Etiology of severe short stature below −3 SDS in a screened Finnish population
  35. Androgen deprivation and SARS-CoV-2 in men with prostate cancer
  36. Loss-of-Function Variants in TBC1D32 Underlie Syndromic Hypopituitarism
  37. Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone
  38. Constitutional delay of puberty versus congenital hypogonadotropic hypogonadism: Genetics, management and updates
  39. Treatment of gonadotropin deficiency during the first year of life: long-term observation and outcome in five boys
  40. Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial
  41. Recombinant Human FSH Treatment Outcomes in Five Boys With Severe Congenital Hypogonadotropic Hypogonadism
  42. The Role of KCNQ1 Mutations and Maternal Beta Blocker Use During Pregnancy in the Growth of Children With Long QT Syndrome
  43. Disorders of sex development: timing of diagnosis and management in a single large tertiary center
  44. GnRH receptor gene mutations in adolescents and young adults presenting with signs of partial gonadotropin deficiency
  45. Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance
  46. Precocious Puberty or Premature Thelarche: Analysis of a Large Patient Series in a Single Tertiary Center with Special Emphasis on 6- to 8-Year-Old Girls
  47. Biliary Anomalies in Patients With HNF1B Diabetes
  48. Congenital hypogonadotropic hypogonadism, functional hypogonadotropism or constitutional delay of growth and puberty? An analysis of a large patient series from a single tertiary center
  49. Detection of Novel Gene Variants Associated with Congenital Hypothyroidism in a Finnish Patient Cohort
  50. Fundus Photography as a Screening Method for Diabetic Retinopathy in Children With Type 1 Diabetes: Outcome of the Initial Photography
  51. Clinical, Genetic, and Biochemical Characteristics of Early-Onset Diabetes in the Finnish Population
  52. Circulating makorin ring finger protein 3 levels decline in boys before the clinical onset of puberty
  53. Childhood growth in boys with congenital hypogonadotropic hypogonadism
  54. Early-Onset Diabetic E1-DN Mice Develop Albuminuria and Glomerular Injury Typical of Diabetic Nephropathy
  55. EGFR Signaling Promotes β-Cell Proliferation and Survivin Expression during Pregnancy
  56. In vivo activation of the PI3K–Akt pathway in mouse beta cells by the EGFR mutation L858R protects against diabetes
  57. Use of Electronic Health Records for Automated Screening of Growth Disorders in Primary Care
  58. Gender Identity and Gender Role Orientation in Female Assigned Patients with Disorders of Sex Development
  59. Prevalence and characteristics of diabetes among Somali children and adolescents living in Helsinki, Finland
  60. Sexual Function and Attitudes Toward Surgery After Feminizing Genitoplasty
  61. Epidermal growth factor (EGF)-receptor signalling is needed for murine beta cell mass expansion in response to high-fat diet and pregnancy but not after pancreatic duct ligation
  62. Sexual Function and Attitudes towards Surgery After Feminizing Genitoplasty
  63. Transcription factor AP-1 promotes growth and radioresistance in prostate cancer cells
  64. EGF-receptor regulates salivary gland branching morphogenesis by supporting proliferation and maturation of epithelial cells and survival of mesenchymal cells
  65. EGF receptor in pancreatic β-cell mass regulation
  66. ERBB receptors in developing, dysplastic and malignant oral epithelia
  67. Hydrocortisone and Indomethacin Negatively Modulate EGF-R Signaling in Human Fetal Intestine
  68. EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways
  69. Downregulation of EGF Receptor Signaling in Pancreatic Islets Causes Diabetes Due to Impaired Postnatal  -Cell Growth
  70. Effects of epidermal growth factor receptor deficiency and 2,3,7,8-tetrachlorodibenzo-p-dioxin on fetal development in mice
  71. Novel splice site CACNA1A mutation causing episodic ataxia type 2
  72. Different Mechanisms of Syndecan-1 Activation through a Fibroblast-growth-factor-inducible Response Element (FiRE) in Mucosal and Cutaneous Wounds
  73. ErbB Signaling Regulates Lineage Determination of Developing Pancreatic Islet Cells in Embryonic Organ Culture
  74. Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor
  75. Uterine and Vaginal Organ Growth Requires Epidermal Growth Factor Receptor Signaling from Stroma1
  76. Impaired Lung Branching Morphogenesis in the Absence of Functional EGF Receptor
  77. A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor
  78. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor
  79. Transforming Growth Factor-α and Epidermal Growth Factor Expression in Human Fetal Gastrointestinal Tract
  80. EGF- and TGF-α-Like Peptides in Human Fetal Gut